Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Centene Corp (CNC) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Top 35% of 4004 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $34.02B large-cap · #5 of 10 peers
Summary

Centene Corp (CNC) stock forecast summary

Our AI ranks Centene Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Centene Corp is a large-cap company with a market capitalization of $34.02B. It ranks number 5 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its P/B Ratio of 1.51x is the lowest of the 10 peers that report one. Its ROE of -22.6% is the lowest of the 8 peers that report one.

A per-ticker accuracy statistic for CNC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CNC included.

Follow CNC free
Price

CNC price chart and AI forecast

CNC
Cross-section · 2026-10-14

How CNC ranks among 4004 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Centene Corp (CNC) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.

Valuation & Market

MetricCNCIndustry medianRank
Market Cap $34.02B $22.48B 5/10
P/B Ratio 1.51x 2.74x 10/10
EPS $-10.35 – –
Book Value/Share $45.67 – –
Revenue/Share $410.81 – –
FCF/Share $18.12 – –

Profitability & Margins

MetricCNCIndustry medianRank
ROE -22.6% 8.6% 8/8
ROA -6.1% 3.2% 8/8
ROIC -13.3% 6.9% 10/10
Gross Margin 98.6% 54.6% 1/6
Operating Margin -2.8% 1.7% 10/10
Net Margin -2.5% 1.9% 8/8
EBT Margin -2.3% 1.4% 10/10
Tax Rate -10.2% – –

Financial Health

MetricCNCIndustry medianRank
Current Ratio 1.15x 1.51x 7/10
D/E Ratio 2.68x 2.38x 4/10
Financial Leverage 3.68x 3.42x 5/10
Interest Coverage 7.7x 7.5x 4/9
Working Capital $5.93B $580M 3/10

Cash Flow

MetricCNCIndustry medianRank
Operating Cash Flow $9.75B $3.13B 3/10
Free Cash Flow $8.95B $1.27B 2/9
Capital Spending -$798M -$94M 7/9
OCF Growth YoY 463.5% 34.4% 1/9
FCF Growth YoY 728.8% 25.9% 1/8
FCF/Sales 4.4% 3.9% 4/9
CapEx/Sales 0.4% 0.4% 6/9

Operational Efficiency

MetricCNCIndustry medianRank
Asset Turnover 2.44x 2.12x 5/10
Fixed Assets Turnover 95.3x 72.4x 4/10

Income Statement

MetricCNCIndustry medianRank
Total Revenue $202.94B $90.86B 3/10
Operating Income -$5.64B $416M 10/10
Net Income -$5.10B $840M 8/8
SG&A Expense $13.02B $13.59B 5/8
Cost of Goods Sold $2.76B $30.37B 5/6

Dividend & Shareholder Information

MetricCNCIndustry medianRank
Shares Outstanding 494M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$46.69B56.2% of assets
Cash & Short-term Investments$24.15B29.1% of assets
Total Liabilities$60.35B72.7% of assets
Quarterly Financial Reports

CNC quarterly financials and insider trading

Industry Peers · Hospital & Medical Service Plans

Centene Corp (CNC) industry peers

Companies classified under the same SEC industry code as Centene Corp (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
CNC Centene Corp ▲ $34.02B – 1.5x
UNH Unitedhealth Group Inc ▲ $339.08B 24.0x 3.4x
ELV Elevance Health, Inc. ▲ $92.23B 18.6x 2.1x
CI Cigna Group ▲ $74.66B 11.6x 1.8x
HUM Humana Inc ▲ $50.47B 39.8x 2.4x
MOH Molina Healthcare, Inc. ▲ $10.94B – 2.6x
OSCR Oscar Health, Inc. ▲ $10.43B 18.9x 5.1x
CLOV Clover Health Investments, Corp. /De ▲ $2.55B – 6.8x
ALHC Alignment Healthcare, Inc. ▲ $1.72B – 6.5x
TRUP Trupanion, Inc. ▼ $1.17B – 2.9x

Where CNC sits on the market map

Finance · Hospital & Medical Service Plans
Explore the map →
News

Centene Corp (CNC) stock news

Loading...

FAQ

Centene Corp (CNC) stock forecast FAQ

What is the Centene Corp (CNC) stock forecast?

Our AI ranks Centene Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Centene Corp stock predictions?

A per-ticker accuracy statistic for CNC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Centene Corp forecasts updated?

Centene Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Centene Corp's industry peers?

10 issuers in our coverage, CNC included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.